SUCCINYLCHOLINE CHLORIDE

Post-LOE

succinylcholine chloride

Merck & Co.

ANDAINJECTIONINJECTABLE

Approved

Sep 1972

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

SUCCINYLCHOLINE CHLORIDE (succinylcholine chloride) by Merck & Co. is blocker. Approved for mechanical ventilation. First approved in 1972.

Drug data last refreshed 19h ago

Mechanism of Action

blocker. As does acetylcholine, it combines with the cholinergic receptors of the motor end plate to produce depolarization. This depolarization may be observed as fasciculations. Subsequent neuromuscular transmission is inhibited so long as adequate concentration of succinylcholine remains at the…

Indications (1)

mechanical ventilation

Worked on SUCCINYLCHOLINE CHLORIDE at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.